Monheim, May 15, 2013 – In keeping with its global commitment to sustainable agriculture, Bayer CropScience announced today its intention to pursue plans to construct a world-scale glufosinate-ammonium herbicide production plant in the United States near Mobile, Alabama. The new facility will contribute significantly to the company’s target of more than doubling global production capacity for this important active ingredient. The start-up of the new plant is anticipated for the fourth quarter of 2015, in time for the 2016 growing season. Discussions with the local authorities in Alabama are progressing well, and Bayer CropScience is confident that it will be able to initiate the next planning steps for the new facility soon.
“In planning this facility, we are responding to urgent calls by farmers and agronomists for an alternative weed control technology to help combat the increasing problem of weed resistance to glyphosate-based products,” said Liam Condon, Bayer CropScience CEO. “The use of glufosinate-ammonium, marketed as Liberty™ herbicide and used with LibertyLink™ seed, continues to grow as farmers experience the powerful performance benefits of this unique system for nonselective control of grass and broadleaf weeds. The rotation of crops, herbicide tolerant traits and herbicidal modes of action are important elements of a sustainable cropping approach,” he emphasized.
The growth of weed resistance has developed even faster than was predicted only a short while ago. According to a 2012 Stratus Agri-Marketing survey of U.S. farmers, research has shown that nearly 50 percent of all growers surveyed confirmed the existence of glyphosate-resistant weeds on their farms, up from 34 percent of farmers surveyed in 2011. The Bayer CropScience product Liberty™ provides the only nonselective alternative that farmers can use to combat weeds, including glyphosate-resistant weeds, and is an asset to any integrated weed management plan. Bayer CropScience currently manufactures Liberty™ herbicide at production plants in Frankfurt, Germany, and Muskegon, Michigan, USA, but the projected demand by farmers for the product is expected to outpace the existing production capacity.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission “Bayer: Science For A Better Life.” Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of nonagricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
Note to editors: A photo in print quality can be downloaded from the internet at www.press.bayer.com and www.press.bayercropscience.com.
Utz Klages, Tel. +49 2173 38-3125 E-Mail: email@example.com
Greg Coffey, Tel. +1 816 242 2340 E-Mail: firstname.lastname@example.org
Find more information at www.bayercropscience.com. kgs (2013-0284E)
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.